Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D06QRY
|
||||
Former ID |
DIB008152
|
||||
Drug Name |
IDN-5390
|
||||
Synonyms |
IDN-5868; IDN-5869; IDN-6140; Paclitaxel derivatives, Indena; 14-OH DAB
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Cancer [ICD9: 140-229; ICD10:C00-C96] | Investigative | [543674] | ||
Company |
Indena SpA
|
||||
Structure |
Download2D MOL |
||||
Formula |
C41H57NO14
|
||||
Canonical SMILES |
[C@]12(C(C(=C([C@H](C2)OC(=O)[C@@H]([C@@H](NC(=O)OC(C)(<br />C)C)CC(C)C)O)C)C(=O)C(=C([C@@H]([C@@]2(CO[C@@H]2CCO)OC(<br />=O)C)[C@@H]1OC(=O)c1ccccc1)C)O)(C)C)O
|
||||
CAS Number |
CAS 191276-31-0
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Tubulin beta | Target Info | Modulator | [543674] | |
PANTHER Pathway | Cytoskeletal regulation by Rho GTPase | ||||
Huntington disease | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.